James E. Klaunig
Impact in
- Biochemistry top 0.2%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 0.1%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Carcinogens and Genotoxicity Assessment 55
- Pharmacology 30
- Drug-Induced Hepatotoxicity and Protection 17
- Co-authors
- Lisa M. KamendulisRandall J. RuchShujun ChengBarbara A. HocevarZemin WangPeter GoldblattXinzhu PuEarl F. Walborg
- Journals
- Toxicological Sciences (21 papers)Carcinogenesis (16 papers)Toxicology and Applied Pharmacology (15 papers)Toxicology Letters (11 papers)Environmental Health Perspectives (10 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
James E. Klaunig
244 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Biochemistry 1.4k
- Pharmacology 1.4k
- Cancer Research 2.3k
- Health, Toxicology and Mutagenesis 2.1k
- Molecular Biology 4.9k
Countries citing papers authored by James E. Klaunig
This map shows the geographic impact of James E. Klaunig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Klaunig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Klaunig more than expected).
Fields of papers citing papers by James E. Klaunig
This network shows the impact of papers produced by James E. Klaunig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Klaunig. The network helps show where James E. Klaunig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James E. Klaunig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 4 | |
| 4 | 2020 | 9 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 47 | |
| 7 | 2018 | 46 | |
| 8 | 2018 | 8 | |
| 9 | 2017 | 40 | |
| 10 | 2017 | 68 | |
| 11 | 2017 | 14 | |
| 12 | A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder | 2016 | 0 |
| 13 | 2016 | 3 | |
| 14 | 2015 | 7 | |
| 15 | Antioxidant vitamin C prevents decline in endothelial function during sitting | 2015 | 2 |
| 16 | 2013 | 181 | |
| 17 | 2003 | 468 | |
| 18 | 1996 | 5 | |
| 19 | 1993 | 16 | |
| 20 | 1990 | 55 |
About James E. Klaunig
James E. Klaunig is a scholar working on Cancer Research, Pharmacology, Chemical Health and Safety, Health, Toxicology and Mutagenesis and Hepatology, having authored 252 papers that have together received 13.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (55 papers), Toxic Organic Pollutants Impact (23 papers), Genomics, phytochemicals, and oxidative stress (21 papers), Liver Disease Diagnosis and Treatment (21 papers), Effects and risks of endocrine disrupting chemicals (20 papers), Drug Transport and Resistance Mechanisms (18 papers), Connexins and lens biology (17 papers) and Drug-Induced Hepatotoxicity and Protection (17 papers). The work is most often cited by research in Biochemistry (1.4k citations), Pharmacology (1.4k citations), Cancer Research (2.3k citations), Health, Toxicology and Mutagenesis (2.1k citations) and Molecular Biology (4.9k citations). James E. Klaunig has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lisa M. Kamendulis, Randall J. Ruch, Shujun Cheng, Barbara A. Hocevar, Zemin Wang, Peter Goldblatt, Xinzhu Pu, Earl F. Walborg, Kyle L. Kolaja and David E. Hinton. Their work appears in journals such as Toxicological Sciences, Carcinogenesis, Toxicology and Applied Pharmacology, Toxicology Letters and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.